Director/Executive Director, Regulatory Affairs jobs in United States
cer-icon
Apply on Employer Site
company-logo

Ottimo Pharma · 11 hours ago

Director/Executive Director, Regulatory Affairs

Ottimo Pharma is a company focused on developing oncology programs, and they are seeking a Director/Executive Director of Regulatory Affairs to oversee regulatory activities for clinical trials. The role involves managing regulatory submissions, collaborating with health authorities, and ensuring compliance with regulatory standards.

BiotechnologyHealth CarePharmaceutical
Hiring Manager
Josh Haggerty
linkedin

Responsibilities

Take end-to-end ownership of regulatory activities for assigned oncology programs, across the full clinical trials cycle, from planning through execution and follow-through
Operate with a “to-do” mentality—anticipating what needs to be done, driving tasks to completion, and ensuring nothing falls through the cracks
Proactively identify regulatory risks, gaps, or delays impacting clinical trial initiation, conduct and expansion and take responsibility for proposing and implementing solutions
Maintain accountability for timelines, quality, and completeness of all regulatory deliverables supporting respective clinical trials
Translate high-level regulatory strategy into clear, executable plans, timelines, and deliverables as aligned with clinical development plans
Lead the preparation, coordination, and submission of INDs, CTAs, amendments, and annual reports, with hands-on involvement as needed
Draft, review, and finalize regulatory documents including briefing packages, agency responses, and meeting documentation
Provide regulatory input into relevant clinical documents including protocol development, amendments, informed consent forms, IB, safety reporting, etc. Support the review and finalization of trial-related regulatory submissions including local ethics submissions as needed
Drive applications for regulatory designations and expedited pathways (e.g., Fast Track, Breakthrough Therapy, Orphan Drug, etc…)
Lead and support interactions with health authorities (FDA, EMA, and others), ensuring thorough preparation and follow-up
In coordination with clinical, preclinical, translation, CMC and quality, ensure regulatory considerations are embedded early and consistently into program plans and execution
Coordinate and manage external regulatory vendors/consultants as well as regulatory interactions with CROs, holding them accountable for high-quality and timely output
Stay current on global regulatory developments, emerging data, and relevant industry news and proactively assess their impact on active and future programs
Step outside of defined responsibilities when needed to ensure overall program success

Qualification

Regulatory AffairsOncology Drug DevelopmentIND/CTA SubmissionsHealth Authority InteractionsRegulatory StrategyAccountabilityCommunication SkillsOwnership

Required

Advanced degree (PhD, MD, PharmD, or MSc) in life sciences, regulatory affairs, or a related field
10+ years of regulatory affairs experience, with a strong track record in oncology drug development

Preferred

Proven hands-on experience leading IND/CTA submissions and early-stage oncology development globally with direct support of clinical trial programs
Direct involvement in health authority interactions, including preparation and follow-up for FDA, EMA and other health authority meetings
Strong understanding of oncology regulatory requirements, preferably for biologics and immuno-oncology agents
Experience working in lean, startup, or high-growth environments with limited infrastructure including having successfully managed external regulatory vendors/consultants
Demonstrated ability to take ownership, work independently, and deliver results without extensive direction
Excellent written and verbal communication skills, with the ability to clearly articulate regulatory strategy and execution needs
A strong sense of urgency, accountability, and pride in delivering high-quality work

Company

Ottimo Pharma

twittertwitter
company-logo
Ottimo Pharma develops innovative cancer therapies using PD1-VEGFR2 antibodies.

Funding

Current Stage
Early Stage
Total Funding
$140M
Key Investors
Medicxi
2024-12-19Series A· $140M
2024-10-28Seed

Leadership Team

leader-logo
David Epstein
Chief Executive Officer
linkedin
Company data provided by crunchbase